S. Navani

Bicalutamide (Casodex) 150 mg plus standard care in early non-metastatic prostate cancer: results from Early Prostate Cancer Trial 24 at a median 7 years' follow-up

M. Wirth, J. Hetherington, D. Wallace, 2007, Prostate Cancer and Prostatic Diseases.

Tamoxifen as prophylaxis for prevention of gynaecomastia and breast pain associated with bicalutamide 150 mg monotherapy in patients with prostate cancer: a randomised, placebo-controlled, dose-response study.

T. Morris, Y. Fradet, J. Armstrong, 2007, European urology.

A double-blind trial comparing nefopam hydrochloride with pentazocine in postoperative pain

V. Oke, S. Navani, Jha Rj, 1989 .